Company Filing History:
Years Active: 1990-1993
Title: The Innovations of Stephen S. Hecht
Introduction
Stephen S. Hecht is a notable inventor based in Larchmont, NY (US). He has made significant contributions to the field of cancer research, particularly in the area of lung tumor inhibition. With a total of 3 patents, Hecht's work has the potential to impact cancer treatment and prevention.
Latest Patents
Hecht's latest patents focus on methods of inhibiting lung tumors using arylalkyl isothiocyanates. One of his key inventions is a method aimed at reducing lung tumor multiplicity and incidence by treating mammals with relatively long-chain arylalkyl isothiocyanates. This method is especially effective against tumors induced by exposure to tobacco-specific nitrosamines. Among the isothiocyanates he has developed are 4-phenylbutyl isothiocyanate, phenylpentyl isothiocyanate, and phenylhexyl isothiocyanate. These compounds are synthesized through a process involving the addition of hydrochlorides of phenylbutylamine, phenylpentylamine, or phenylhexylamine in water to thiophosgene in an inert organic solvent. For comparison testing, oxo-pyridyl butyl isothiocyanate is synthesized by dissolving myosmine in HCl to obtain a hydrochloride salt, which is then suspended in dry chloroform, followed by the addition of thiophosgene and chloroform containing triethylamine.
Career Highlights
Hecht is associated with the American Health Foundation, where he continues to advance his research and innovations. His work is crucial in the ongoing battle against cancer, particularly lung cancer, which remains a significant health challenge.
Collaborations
Hecht has collaborated with notable colleagues such as Fung-Lung Chung and Karin Eklind, contributing to a collaborative environment that fosters innovation and research excellence.
Conclusion
Stephen S. Hecht's contributions to cancer research through his innovative patents highlight the importance of scientific inquiry in addressing critical health issues. His work not only showcases his expertise but also offers hope for advancements in cancer treatment.